On Nov 05, 2025, CNMD reported earnings of 1.08 USD per share (EPS) for Q3 25, beating the estimate of 1.07 USD, resulting in a 0.66% surprise. Revenue reached 337.93 million, compared to an expected 341.45 million, with a -1.03% difference. The market reacted with a -0.52% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of 1.34 USD, with revenue projected to reach 374.13 million USD, implying an increase of 24.07% EPS, and increase of 10.71% in Revenue from the last quarter.
FAQ
What were CONMED Corporation's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, CONMED Corporation reported EPS of $1.08, beating estimates by 0.66%, and revenue of $337.93M, -1.03% below expectations.
How did the market react to CONMED Corporation's Q3 2025 earnings?
The stock price moved down -0.52%, changed from $44.44 before the earnings release to $44.21 the day after.
When is CONMED Corporation expected to report next?
The next earning report is scheduled for Jan 29, 2026.
What are the forecasts for CONMED Corporation's next earnings report?
Based on 8
analysts, CONMED Corporation is expected to report EPS of $1.34 and revenue of $374.13M for Q4 2025.